<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00589797</url>
  </required_header>
  <id_info>
    <org_study_id>ASC-01</org_study_id>
    <nct_id>NCT00589797</nct_id>
  </id_info>
  <brief_title>Activ-L™ Artificial Disc Treatment of Degenerative Disc Disease in the Treatment of Degenerative Disc Disease</brief_title>
  <official_title>Clinical Study to Evaluate the Safety and Effectiveness of the Aesculap Activ-L™ Artificial Disc in the Treatment of Degenerative Disc Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aesculap Implant Systems</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aesculap Implant Systems</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to learn whether an investigational device called the Activ-L
      Artificial Disc is safe and effective in the treatment of degenerative disc disease of the
      lower (lumbar) spine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this clinical study is to evaluate the safety and effectiveness of the
      Activ-L Artificial Disc for treatment of single-level degenerative disc disease of the lumbar
      spine in patients who have been unresponsive to at least six months of prior conservative
      care. The hypothesis of the study is that the Activ-L Disc is non-inferior to the control
      (the Charité® Artificial Disc [DePuy Spine] or ProDisc-L® Total Disc Replacement [Synthes
      Spine]) with respect to the rate of individual subject success at 24 months. Individual
      subject success is a composite of effectiveness and safety.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2007</start_date>
  <completion_date type="Actual">January 2017</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Overall Success at 24 Months Relative to Baseline</measure>
    <time_frame>24 months</time_frame>
    <description>Measured by absence of treatment failure; absence or serious device related AE; maintenance or improvement of ROM at index level; maintenance or improvement of neurological status; improvement in ODI score.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Device Success</measure>
    <time_frame>24 months</time_frame>
    <description>Percent of subjects demonstrating no Subsequent Surgical Interventions (SSI's) at the index level (L4-L5 or L5-S1) at 24 months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Absence of Serious Device Related Adverse Events</measure>
    <time_frame>24 months</time_frame>
    <description>Percent of subjects demonstrating no device related SAE's at 24 months as per the Clinical Events Committee (CEC)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Range of Motion (ROM) Success</measure>
    <time_frame>24 months</time_frame>
    <description>Percent of subjects demonstrating maintenance or improvement in ROM at 24 months compared to baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neurological Success</measure>
    <time_frame>24 months</time_frame>
    <description>Percent of patients demonstrating maintenance or improvement in combined motor and sensory evaluations at 24 months compared to baseline</description>
  </primary_outcome>
  <primary_outcome>
    <measure>ODI Success</measure>
    <time_frame>24 months</time_frame>
    <description>Percent of subjects demonstrating an improvement of greater than or equal to 15 points at 24 months compared to baseline</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>VAS Success for Back and Leg Pain at Rest</measure>
    <time_frame>24 months</time_frame>
    <description>Number of patients demonstrating improvement in back and leg pain at 24 months compared to baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ODI Success Using Two Measures of Success</measure>
    <time_frame>24 months</time_frame>
    <description>Number of subjects demonstrating improvement in two measures of ODI success at 24 months compared to baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improvement in SF-36 Scores</measure>
    <time_frame>24 months</time_frame>
    <description>Number of subjects demonstrating a greater than or equal to 15% improvement in mental (MCS) and physical (PCS) component summary scores at 24 months compared to baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">376</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <arm_group>
    <arm_group_label>Investigational</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Implantation of either the ProDisc-L Total Disc Replacement or Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Activ-L Artificial Disc</intervention_name>
    <description>Implantation at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
    <arm_group_label>Investigational</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ProDisc-L Total Disc Replacement or Charité Artificial Disc</intervention_name>
    <description>Implantation at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age 18 - 60, skeletally mature

          -  Symptomatic DDD with objective evidence of lumbar DDD, with any of the following
             characteristics by MRI scan:

               -  instability as defined by ≥ 3mm translation or ≥ 5° angulation.

               -  osteophyte formation of facet joints or vertebral endplates.

               -  decreased disc height of &gt;2mm as compared to the adjacent level.

               -  scarring/thickening of the ligamentum flavum, annulus fibrosis, or facet joint
                  capsule.

               -  herniated nucleus pulposus.

               -  facet joint degeneration/changes.

               -  vacuum phenomenon.

          -  Single level symptomatic disease at L4/L5 or L5/S1.

               -  six months of unsuccessful conservative treatment

          -  ODI score ≥ 40/100.

          -  Surgical candidate for an anterior approach to the lumbar spine.

          -  Back pain at the operative level only, with or without leg pain.

          -  Back pain VAS score greater than the higher of the two VAS leg pain scores.

          -  VAS back pain score ≥ 40/100 mm.

          -  Willing to return for follow-up visits and sign an Informed Consent and HIPAA
             Authorization.

        Exclusion Criteria:

          -  Previous surgery at any lumbar level, except IDET (Intradiscal Electrothermal
             Annuloplasty), percutaneous nucleoplasty, or microdiscectomy.

          -  Chronic radiculopathy, i.e., subject complaint of unremitting pain with a predominance
             of leg pain symptoms greater than back pain symptoms extending over a period of at
             least 1 year.

          -  endplate dimensions smaller than 34.5 mm in medial-lateral and/or 27 mm in the
             anterior-posterior direction

          -  Evidence of significant, symptomatic disc degeneration at another lumbar level.

          -  Preoperative remaining disc height &lt; 3mm

          -  Myelopathy.

          -  Previous compression or burst fracture at the affected level.

          -  Sequestered herniated nucleus pulposus with migration.

          -  Mid-sagittal stenosis of &lt;8mm (by MRI).

          -  Degenerative or lytic spondylolisthesis &gt; 3mm.

          -  Spondylolysis.

          -  Isthmic spondylolisthesis.

          -  Lumbar scoliosis (&gt; 11 degrees of sagittal plane deformity).

          -  Spinal tumor.

          -  Active systemic infection or infection at the site of surgery.

          -  Facet ankylosis or severe facet degeneration.

          -  Continuing steroid use or prior use for more than 2 months.

          -  History of allergies to any of the device components.

          -  Pregnancy or planning to become pregnant within the next 2 years.

          -  Morbid obesity (BMI &gt;35).

          -  Investigational drug or device use within 30 days.

          -  Osteoporosis or osteopenia

          -  Metabolic bone disease.

          -  Leg pain with migrated sequestrum fragment.

          -  History of rheumatoid arthritis, lupus, or other autoimmune disorder.

          -  Ankylosing spondylitis.

          -  History of HIV/AIDS or hepatitis that precludes surgery.

          -  History of deep vein thrombosis, symptoms of arterial insufficiency, or
             thromboembolytic disease.

          -  Current or recent history of illicit drug or alcohol abuse, or dependence as defined
             as the continued use of alcohol despite the development of social, legal, or health
             problems.

          -  Life expectancy &lt;5 years.

          -  Chemotherapy within past 5 years or any cancer other than non-melanoma skin cancer
             treated with curative intent within the past 5 years.

          -  Prior nephrectomy.

          -  Abdominal adhesions, endometriosis, inflammatory bowel disease, Crohn's disease,
             diverticulitis, ulcerative colitis or other abdominal pathology that would preclude
             abdominal surgical approach.

          -  Insulin-dependent diabetes.

          -  Any degenerative muscular or neurological condition that would interfere with
             evaluation of outcomes, including but not limited to Parkinson's disease, ALS
             (amyotrophic lateral sclerosis), or multiple sclerosis.

          -  History of Pelvic Inflammatory Disease.

          -  Peritonitis.

          -  Currently in active spinal litigation as a result of medical negligence.

          -  Prisoner.

          -  Psychiatric or cognitive impairment that would interfere with the subject's ability to
             comply with the study requirements, e.g., Alzheimer's disease.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rolando Garcia, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Orthopedic Care Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James J Yue, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Yale University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dom Coric, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Carolina Neurosurgery and Spine Associates</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Steven Dennis, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hoag Memorial Hospital Presbyterian</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Federico P. Girardi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital for Special Surgery, New York</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mick Perez-Cruet, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Michigan Head and Spine Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Harel Deutsch, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rush University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Glenn Buttermann, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Midwest Spine Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dzung Dinh, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Neuroscience Education and Research Foundation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Vikas Patel, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Colorado, Denver</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christopher Ames, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, San Francisco</affiliation>
  </overall_official>
  <overall_official>
    <last_name>John Regan, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. John's Hospital and Health Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Andrew Dailey, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Utah Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Darren Bergey, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Rancho Specialty Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brian Dalton, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hamot Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Scott Leary, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Scripps Memorial Hospital La Jolla</affiliation>
  </overall_official>
  <overall_official>
    <last_name>David Hart, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospitals Cleveland</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Castellvi, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Foundatin for Orthopaedic Research and Education</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Scripps Memorial Hospital La Jolla</name>
      <address>
        <city>La Jolla</city>
        <state>California</state>
        <zip>92037</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hoag Memorial Hospital Presbyterian</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92658</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rancho Specialty Hospital</name>
      <address>
        <city>Rancho Cucamonga</city>
        <state>California</state>
        <zip>91730</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of California San Francisco</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94143</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. John's Hospital and Health Center</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>90404</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Colorado Health Sciences Center</name>
      <address>
        <city>Aurora</city>
        <state>Colorado</state>
        <zip>80045</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Yale University School of Medicine/New Haven Hospital</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06520</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Aventura Hospital and Medical Center</name>
      <address>
        <city>Aventura</city>
        <state>Florida</state>
        <zip>33180</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Community Hospital</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33613</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Neurosciences Education and Research Foundation</name>
      <address>
        <city>Peoria</city>
        <state>Illinois</state>
        <zip>61605</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>HealthEast St. John's Hospital</name>
      <address>
        <city>Maplewood</city>
        <state>Minnesota</state>
        <zip>55109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital for Special Surgery</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10021</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Carolinas Healthcare</name>
      <address>
        <city>Charlotte</city>
        <state>North Carolina</state>
        <zip>28203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospitals of Cleveland</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hamot Medical Center</name>
      <address>
        <city>Erie</city>
        <state>Pennsylvania</state>
        <zip>16507</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Utah</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84112</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>December 26, 2007</study_first_submitted>
  <study_first_submitted_qc>December 26, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 10, 2008</study_first_posted>
  <results_first_submitted>January 27, 2016</results_first_submitted>
  <results_first_submitted_qc>November 12, 2018</results_first_submitted_qc>
  <results_first_posted type="Actual">December 7, 2018</results_first_posted>
  <last_update_submitted>November 12, 2018</last_update_submitted>
  <last_update_submitted_qc>November 12, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 7, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Degenerative</keyword>
  <keyword>Disc</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Spinal Diseases</mesh_term>
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Subjects were screened and enrolled at 19 US health care center sites</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>Investigational</title>
          <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1</description>
        </group>
        <group group_id="P2">
          <title>Control</title>
          <description>Implantation of either the ProDisc Total Disc Replacement or the Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="264"/>
                <participants group_id="P2" count="112"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>Baseline</title>
              <participants_list>
                <participants group_id="P1" count="218"/>
                <participants group_id="P2" count="106"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>24 Months</title>
              <participants_list>
                <participants group_id="P1" count="191"/>
                <participants group_id="P2" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="191"/>
                <participants group_id="P2" count="89"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="73"/>
                <participants group_id="P2" count="23"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Death</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="12"/>
                <participants group_id="P2" count="9"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="8"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Non-Randomized Training Subjects</title>
              <participants_list>
                <participants group_id="P1" count="46"/>
                <participants group_id="P2" count="6"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All enrolled subjects</population>
      <group_list>
        <group group_id="B1">
          <title>Investigational</title>
          <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1</description>
        </group>
        <group group_id="B2">
          <title>Control</title>
          <description>Implantation of either the ProDisc Total Disc Replacement or the Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="264"/>
            <count group_id="B2" value="112"/>
            <count group_id="B3" value="376"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <description>All enrolled subjects</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="264"/>
                    <measurement group_id="B2" value="112"/>
                    <measurement group_id="B3" value="376"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <description>All enrolled subjects</description>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.1" spread="8.6"/>
                    <measurement group_id="B2" value="40.0" spread="8.6"/>
                    <measurement group_id="B3" value="39.6" spread="8.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <description>All enrolled subjects</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="124"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="180"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="140"/>
                    <measurement group_id="B2" value="56"/>
                    <measurement group_id="B3" value="196"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <description>All enrolled subjects</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="29"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="235"/>
                    <measurement group_id="B2" value="100"/>
                    <measurement group_id="B3" value="335"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <description>All enrolled subjects</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="3"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="23"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="233"/>
                    <measurement group_id="B2" value="106"/>
                    <measurement group_id="B3" value="339"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Oswestry Disability Index (ODI) Scores for Low Back Pain</title>
          <description>Scores on a scale from 0 (minimal disability) to 100 (bed-bound)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="57.1" spread="13.9"/>
                    <measurement group_id="B2" value="58.6" spread="14.1"/>
                    <measurement group_id="B3" value="57.9" spread="13.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Visual Analog Scale (VAS) Ratings for Back and Leg Pain</title>
          <description>Ratings on a scale from 0 (no pain) to 100 (worst possible pain)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>VAS Back Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="79.0" spread="14.9"/>
                    <measurement group_id="B2" value="79.1" spread="14.8"/>
                    <measurement group_id="B3" value="79.1" spread="14.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS Right Leg Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.7" spread="29.8"/>
                    <measurement group_id="B2" value="32.9" spread="29.6"/>
                    <measurement group_id="B3" value="30.6" spread="30.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS Left Leg Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.6" spread="29.4"/>
                    <measurement group_id="B2" value="30.7" spread="29.5"/>
                    <measurement group_id="B3" value="30.4" spread="29.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Short-Form (36) Health Questionnaire (SF-36) Scores</title>
          <description>Scores on a scale from 0 (maximum disability) to 100 (no disability) for mental component summary (MCS) and physical component summary (PCS)</description>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>SF-36 MCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="39.1" spread="13.9"/>
                    <measurement group_id="B2" value="39.6" spread="14.9"/>
                    <measurement group_id="B3" value="39.4" spread="14.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF-36 PCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="29.9" spread="6.2"/>
                    <measurement group_id="B2" value="28.4" spread="6.2"/>
                    <measurement group_id="B3" value="29.2" spread="6.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Rotational Range of Motion</title>
          <units>degrees</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <title>Flexion/Extension</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.6" spread="5.1"/>
                    <measurement group_id="B2" value="6.6" spread="4.6"/>
                    <measurement group_id="B3" value="6.6" spread="4.8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Lateral Bending AP</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="1.0" spread="2.0"/>
                    <measurement group_id="B2" value="1.0" spread="1.8"/>
                    <measurement group_id="B3" value="1.0" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Translational Range of Motion</title>
          <units>millimeters</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0.5" spread="0.7"/>
                    <measurement group_id="B2" value="0.6" spread="0.6"/>
                    <measurement group_id="B3" value="0.6" spread="0.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Normal Neurological Status</title>
          <description>Number of subjects meeting the following criteria for normal status: Motor - Grade 5 (active movement vs. full resistance); Sensory - Grade 2 (normal); Reflexes - Grade 2 (normal)</description>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Motor</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="97"/>
                    <measurement group_id="B2" value="40"/>
                    <measurement group_id="B3" value="137"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sensory</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="78"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="111"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Reflexes</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="91"/>
                    <measurement group_id="B2" value="42"/>
                    <measurement group_id="B3" value="133"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Overall Success at 24 Months Relative to Baseline</title>
        <description>Measured by absence of treatment failure; absence or serious device related AE; maintenance or improvement of ROM at index level; maintenance or improvement of neurological status; improvement in ODI score.</description>
        <time_frame>24 months</time_frame>
        <population>Intent to treat population; missing data imputed as failures</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational</title>
            <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Implantation of either the ProDisc Total Disc Replacement or the Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Success at 24 Months Relative to Baseline</title>
          <description>Measured by absence of treatment failure; absence or serious device related AE; maintenance or improvement of ROM at index level; maintenance or improvement of neurological status; improvement in ODI score.</description>
          <population>Intent to treat population; missing data imputed as failures</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="106"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Including ROM success component</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="42.2" lower_limit="35.6" upper_limit="49.1"/>
                    <measurement group_id="O2" value="28.3" lower_limit="20.0" upper_limit="37.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Without ROM success component</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="61.9" lower_limit="55.1" upper_limit="68.4"/>
                    <measurement group_id="O2" value="52.8" lower_limit="42.9" upper_limit="62.6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>The trial was designed as a non-inferiority trial with a margin (delta) of 15%. Additional analyses using a delta of 10% as requested by FDA were also conducted.</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>t-test, 1 sided</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>VAS Success for Back and Leg Pain at Rest</title>
        <description>Number of patients demonstrating improvement in back and leg pain at 24 months compared to baseline</description>
        <time_frame>24 months</time_frame>
        <population>Intent to treat population; observed data (i.e. missing data not imputed as failures)</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational</title>
            <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Implantation of either the ProDisc Total Disc Replacement or the Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
          </group>
        </group_list>
        <measure>
          <title>VAS Success for Back and Leg Pain at Rest</title>
          <description>Number of patients demonstrating improvement in back and leg pain at 24 months compared to baseline</description>
          <population>Intent to treat population; observed data (i.e. missing data not imputed as failures)</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="180"/>
                <count group_id="O2" value="84"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>VAS Rating for Back Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="162"/>
                    <measurement group_id="O2" value="72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS Rating for Left Leg Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72"/>
                    <measurement group_id="O2" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>VAS Rating for Right Leg Pain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73"/>
                    <measurement group_id="O2" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Device Success</title>
        <description>Percent of subjects demonstrating no Subsequent Surgical Interventions (SSI's) at the index level (L4-L5 or L5-S1) at 24 months.</description>
        <time_frame>24 months</time_frame>
        <population>Intent to treat population; missing data imputed as failures</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational</title>
            <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Implantation of either the ProDisc Total Disc Replacement or the Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
          </group>
        </group_list>
        <measure>
          <title>Device Success</title>
          <description>Percent of subjects demonstrating no Subsequent Surgical Interventions (SSI's) at the index level (L4-L5 or L5-S1) at 24 months.</description>
          <population>Intent to treat population; missing data imputed as failures</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="106"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="84.4" lower_limit="78.9" upper_limit="89.0"/>
                    <measurement group_id="O2" value="84.9" lower_limit="76.6" upper_limit="91.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Absence of Serious Device Related Adverse Events</title>
        <description>Percent of subjects demonstrating no device related SAE's at 24 months as per the Clinical Events Committee (CEC)</description>
        <time_frame>24 months</time_frame>
        <population>Intent to treat population; missing data imputed as failures</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational</title>
            <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Implantation of either the ProDisc Total Disc Replacement or the Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
          </group>
        </group_list>
        <measure>
          <title>Absence of Serious Device Related Adverse Events</title>
          <description>Percent of subjects demonstrating no device related SAE's at 24 months as per the Clinical Events Committee (CEC)</description>
          <population>Intent to treat population; missing data imputed as failures</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="106"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="76.6" lower_limit="70.4" upper_limit="82.1"/>
                    <measurement group_id="O2" value="70.8" lower_limit="61.1" upper_limit="79.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Range of Motion (ROM) Success</title>
        <description>Percent of subjects demonstrating maintenance or improvement in ROM at 24 months compared to baseline</description>
        <time_frame>24 months</time_frame>
        <population>Intent to treat population; missing data imputed as failures</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational</title>
            <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Implantation of either the ProDisc Total Disc Replacement or the Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
          </group>
        </group_list>
        <measure>
          <title>Range of Motion (ROM) Success</title>
          <description>Percent of subjects demonstrating maintenance or improvement in ROM at 24 months compared to baseline</description>
          <population>Intent to treat population; missing data imputed as failures</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="106"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58.7" lower_limit="51.9" upper_limit="65.3"/>
                    <measurement group_id="O2" value="42.5" lower_limit="32.9" upper_limit="52.4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>Neurological Success</title>
        <description>Percent of patients demonstrating maintenance or improvement in combined motor and sensory evaluations at 24 months compared to baseline</description>
        <time_frame>24 months</time_frame>
        <population>Intent to treat population; missing data imputed as failures</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational</title>
            <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Implantation of either the ProDisc Total Disc Replacement or the Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
          </group>
        </group_list>
        <measure>
          <title>Neurological Success</title>
          <description>Percent of patients demonstrating maintenance or improvement in combined motor and sensory evaluations at 24 months compared to baseline</description>
          <population>Intent to treat population; missing data imputed as failures</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="106"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="80.3" lower_limit="74.4" upper_limit="85.3"/>
                    <measurement group_id="O2" value="76.4" lower_limit="67.2" upper_limit="84.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Primary</type>
        <title>ODI Success</title>
        <description>Percent of subjects demonstrating an improvement of greater than or equal to 15 points at 24 months compared to baseline</description>
        <time_frame>24 months</time_frame>
        <population>Intent to treat population; missing data imputed as failures</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational</title>
            <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Implantation of either the ProDisc Total Disc Replacement or the Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
          </group>
        </group_list>
        <measure>
          <title>ODI Success</title>
          <description>Percent of subjects demonstrating an improvement of greater than or equal to 15 points at 24 months compared to baseline</description>
          <population>Intent to treat population; missing data imputed as failures</population>
          <units>percentage of participants</units>
          <param>Number</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="218"/>
                <count group_id="O2" value="106"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="75.2" lower_limit="68.9" upper_limit="80.8"/>
                    <measurement group_id="O2" value="66.0" lower_limit="56.2" upper_limit="75.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>ODI Success Using Two Measures of Success</title>
        <description>Number of subjects demonstrating improvement in two measures of ODI success at 24 months compared to baseline</description>
        <time_frame>24 months</time_frame>
        <population>Intent to treat population; observational data (i.e. missing data not imputed as failures)</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational</title>
            <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Implantation of either the ProDisc Total Disc Replacement or the Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
          </group>
        </group_list>
        <measure>
          <title>ODI Success Using Two Measures of Success</title>
          <description>Number of subjects demonstrating improvement in two measures of ODI success at 24 months compared to baseline</description>
          <population>Intent to treat population; observational data (i.e. missing data not imputed as failures)</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="187"/>
                <count group_id="O2" value="87"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Greater than or equal to 15 points of improvement</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="164"/>
                    <measurement group_id="O2" value="70"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Greater than or equal to 15% improvement</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="170"/>
                    <measurement group_id="O2" value="77"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Improvement in SF-36 Scores</title>
        <description>Number of subjects demonstrating a greater than or equal to 15% improvement in mental (MCS) and physical (PCS) component summary scores at 24 months compared to baseline</description>
        <time_frame>24 months</time_frame>
        <population>Intent to treat population; observational data (i.e. missing data not imputed as failures)</population>
        <group_list>
          <group group_id="O1">
            <title>Investigational</title>
            <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1</description>
          </group>
          <group group_id="O2">
            <title>Control</title>
            <description>Implantation of either the ProDisc Total Disc Replacement or the Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
          </group>
        </group_list>
        <measure>
          <title>Improvement in SF-36 Scores</title>
          <description>Number of subjects demonstrating a greater than or equal to 15% improvement in mental (MCS) and physical (PCS) component summary scores at 24 months compared to baseline</description>
          <population>Intent to treat population; observational data (i.e. missing data not imputed as failures)</population>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="180"/>
                <count group_id="O2" value="86"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>SF-36 MCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="101"/>
                    <measurement group_id="O2" value="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>SF-36 PCS</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="156"/>
                    <measurement group_id="O2" value="69"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Serious and Non-Serious Adverse Events Adjudicated as of 9 October 2015</time_frame>
      <desc>All anticipated and unanticipated serious and non-serious adverse events in the intent to treat population</desc>
      <group_list>
        <group group_id="E1">
          <title>Investigational</title>
          <description>Implantation of the Activ-L Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1</description>
        </group>
        <group group_id="E2">
          <title>Control</title>
          <description>Implantation of either the ProDisc Total Disc Replacement or the Charité Artificial Disc at one level of the lumbar spine, either L4/L5 or L5/S1.</description>
        </group>
      </group_list>
      <serious_events>
        <default_vocab>Custom</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="86" subjects_at_risk="218"/>
                <counts group_id="E2" subjects_affected="57" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>High Cholesterol</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Issues</sub_title>
                <description>Includes arrhythmia, chest pain, heart disease and myocardial infarct</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Eyes, Ears, Nose or Throat Issues</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes Mellitus</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Goiter</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Esophageal Issues</sub_title>
                <description>Includes esophageal bleeding and esophagitis</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Gastric Issues</sub_title>
                <description>Includes abdominal pain, stomach flu, gastric infection and peptic ulcer</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="218"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Intestinal Issues</sub_title>
                <description>Includes appendicitis and bowel obstruction</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="218"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Other GI Issues</sub_title>
                <description>Includes weight gain, colonoscopy and hernia repair</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>Gall Bladder Issues</sub_title>
                <description>Includes cholecystectomy, cholecystitis and gallstones</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="218"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Liver Fibrosis</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Fever</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Sjogren's Syndrome</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Systemic Allergic Reaction</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Systemic Infection</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Trauma</sub_title>
                <description>Includes motor vehicle accident, fall, trip, slip or twist</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Bone Fracture - Lumbar</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Bone Fracture - Non-Lumbar</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Degenerative Joint Disease - Lumbar</sub_title>
                <description>Includes arthritis, facet joint degeneration and rheumatoid arthritis</description>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Degenerative Joint Disease - Non-Lumbar</sub_title>
                <description>Includes inflammatory polyarthritis</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Joint or Muscle Issues</sub_title>
                <description>Includes ganglion cyst, hallux rigidus, hip-joint pain, surgery, torn meniscus and trigger finger</description>
                <counts group_id="E1" events="11" subjects_affected="10" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Muscle Spasm</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Non-Lumbar Radiographic Observation</sub_title>
                <description>Includes disc bulge and disc herniation</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="218"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Pain in Non-Lumbar or Leg</sub_title>
                <description>Includes neck and thoracic</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="218"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Plantar Fascitis</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Neoplasms benign, malignant and unspecified (incl cysts and polyps)</title>
            <event_list>
              <event>
                <sub_title>Cancer</sub_title>
                <description>Includes breast, colon, prostate, rectal, skin and vulvar</description>
                <counts group_id="E1" events="14" subjects_affected="11" subjects_at_risk="218"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Lower Extremity Pain</sub_title>
                <description>Includes bilateral lower leg, unilateral upper and lower leg</description>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="218"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Lumbar Only Pain</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="218"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Lumbar and Lower Extremeties Sensory Deficit</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Lumbar and Lower Extremities Motor Deficit</sub_title>
                <description>Includes general and transient unilateral motor deficit</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Lumbar and Lower Extremity Pain</sub_title>
                <description>Includes lumbar + unilateral and bilateral radiation into upper and lower leg</description>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="218"/>
                <counts group_id="E2" events="8" subjects_affected="8" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Non-Lumbar and Lower Extremities Deficit</sub_title>
                <description>Includes brain tumor, headache, loss of consciousness, nerve entrapment, seizure, vertigo and carpal tunnel syndrome</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="218"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Pregnancy Related Issues</sub_title>
                <description>Includes pregnancy, delivery and miscarriages</description>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychosocial Disorders</sub_title>
                <description>Includes conversion disorder, depression and suicidal attempt</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Substance Related Disorders</sub_title>
                <description>Includes substance dependence and withdrawal</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="218"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Suicide</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Benign Prostatic Hypertrophy</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Kidney Issues</sub_title>
                <description>Includes kidney stones</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Female Reproductive System Issues</sub_title>
                <description>Includes breast implant leakage, irregular menstrual bleeding and ovarian or uterine cyst or mass or tumor</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="218"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Male Reproductive System Issues</sub_title>
                <description>Includes erectile dysfunction and retrograde ejaculation</description>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="218"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Reproductive System Related Surgeries</sub_title>
                <description>Includes breast reduction or enhancement and hysterectomy</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Breathing Disorders</sub_title>
                <description>Includes dyspnea</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Respiratory Infections</sub_title>
                <description>Includes bronchitis and pneumonia</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="218"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Device Deficiency</sub_title>
                <description>Includes implant expulsion, malposition, migration and subsidence</description>
                <counts group_id="E1" events="7" subjects_affected="7" subjects_at_risk="218"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Index Procedure Related Wounds</sub_title>
                <description>Includes deep wounds, dural injuries and incisional hernia</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="218"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Subsequent Surgical Intervention Procedure Related Wounds</sub_title>
                <description>Includes incisional hernia</description>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Blood Loss</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Blood Pressure</sub_title>
                <description>Includes syncope</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Embolism</sub_title>
                <description>Includes pulmonary embolism</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Thrombosis</sub_title>
                <description>Includes deep vein thrombosis</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Vascular Issues</sub_title>
                <description>Includes aneurysm, atherosclerosis and iliac vessel tear</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="218"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>2</frequency_threshold>
        <default_vocab>Custom</default_vocab>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="197" subjects_at_risk="218"/>
                <counts group_id="E2" subjects_affected="100" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Blood and lymphatic system disorders</title>
            <event_list>
              <event>
                <sub_title>Anemia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="218"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>High Cholesterol</sub_title>
                <counts group_id="E1" events="5" subjects_affected="5" subjects_at_risk="218"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Cardiac disorders</title>
            <event_list>
              <event>
                <sub_title>Cardiac Issues</sub_title>
                <description>Includes arrhythmia, chest pain, heart disease and myocardial infarct</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="218"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Ear and labyrinth disorders</title>
            <event_list>
              <event>
                <sub_title>Eyes, Ears, Nose or Throat</sub_title>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="218"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Endocrine disorders</title>
            <event_list>
              <event>
                <sub_title>Diabetes Mellitus</sub_title>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Gastric Issues</sub_title>
                <description>Includes abdominal adhesion, abdominal pain, acid reflux, indigestion, food poisoning, GERD, gastric lesions, gastritis, stomach flu, gastrointestinal infection and peptic ulcer</description>
                <counts group_id="E1" events="27" subjects_affected="27" subjects_at_risk="218"/>
                <counts group_id="E2" events="10" subjects_affected="9" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Intestinal Issues</sub_title>
                <description>Includes bowel irregularity, constipation, diverticulitis, GI bleed, inflammatory bowel syndrome, nausea, vomiting and diarrhea</description>
                <counts group_id="E1" events="17" subjects_affected="16" subjects_at_risk="218"/>
                <counts group_id="E2" events="13" subjects_affected="11" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Immune system disorders</title>
            <event_list>
              <event>
                <sub_title>Non-Procedure Allergic Reactions</sub_title>
                <description>Includes seasonal and systemic allergic reactions</description>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="218"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Infections and infestations</title>
            <event_list>
              <event>
                <sub_title>Infections</sub_title>
                <description>Includes abscess, cellulitis and non-procedure wound infections</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="218"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Injury, poisoning and procedural complications</title>
            <event_list>
              <event>
                <sub_title>Trauma</sub_title>
                <description>Includes motor vehicle accident, fall, trip, slip or twist</description>
                <counts group_id="E1" events="50" subjects_affected="38" subjects_at_risk="218"/>
                <counts group_id="E2" events="27" subjects_affected="21" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Degenerative Joint Disease - Lumbar</sub_title>
                <description>Includes ankylosing spondylitis, arthritis, arthropathy and facet joint degeneration</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Plantar Fascitis</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="218"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Joint or Muscle Issues</sub_title>
                <description>Includes non-lumbar benign mass or tumor, bursitis, ganglion cyst, gout, hallux rigidus, hiccups, hip joint pain, non-lumbar joint sprain, leg length discrepancy, SI joint pain, surgery, torn meniscus, torn hip labral tear and trigger finger</description>
                <counts group_id="E1" events="22" subjects_affected="19" subjects_at_risk="218"/>
                <counts group_id="E2" events="13" subjects_affected="11" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Pain in Non-Lumbar or Leg</sub_title>
                <description>Includes ankle, back, upper extremities, neck and thoracic, fibromyalgia, and foot</description>
                <counts group_id="E1" events="54" subjects_affected="45" subjects_at_risk="218"/>
                <counts group_id="E2" events="15" subjects_affected="14" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Lumbar and Lower Extremity Motor Deficit</sub_title>
                <description>Includes general, persistent and transient unilateral and bilateral motor deficit</description>
                <counts group_id="E1" events="7" subjects_affected="6" subjects_at_risk="218"/>
                <counts group_id="E2" events="6" subjects_affected="5" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Lumbar and Lower Extremity Sensory Deficit</sub_title>
                <description>Includes unilateral and bilateral general and upper extremity sensory deficit, positive or change in SLR test</description>
                <counts group_id="E1" events="25" subjects_affected="24" subjects_at_risk="218"/>
                <counts group_id="E2" events="18" subjects_affected="16" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Reflex Change or Abnormality</sub_title>
                <counts group_id="E1" events="6" subjects_affected="5" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Non-Lumbar and Lower Extremity Deficit</sub_title>
                <description>Includes Bell's palsy, brain tumor, dysphagia, memory loss, headache, loss of consciousness, migraine, nerve entrapment, numbness, restlessness, seizure, tremor, vertigo, carpal tunnel, peripheral neuropathy, upper extremity motor/sensory deficits</description>
                <counts group_id="E1" events="19" subjects_affected="18" subjects_at_risk="218"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Lower Extremity Pain</sub_title>
                <description>Includes unilateral and bilateral upper and lower leg</description>
                <counts group_id="E1" events="45" subjects_affected="40" subjects_at_risk="218"/>
                <counts group_id="E2" events="15" subjects_affected="11" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Lumbar Only Pain</sub_title>
                <counts group_id="E1" events="48" subjects_affected="44" subjects_at_risk="218"/>
                <counts group_id="E2" events="31" subjects_affected="30" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Lumbar and Lower Extremity Pain</sub_title>
                <description>Includes lumbar + unilateral and bilateral radiation into upper and lower leg</description>
                <counts group_id="E1" events="42" subjects_affected="42" subjects_at_risk="218"/>
                <counts group_id="E2" events="23" subjects_affected="23" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Pregnancy, puerperium and perinatal conditions</title>
            <event_list>
              <event>
                <sub_title>Pregnancy Related Issues</sub_title>
                <description>Includes pregnancy and delivery</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="218"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Psychiatric disorders</title>
            <event_list>
              <event>
                <sub_title>Psychosocial Disorders</sub_title>
                <description>Includes anxiety, bipolar and depressive disorders</description>
                <counts group_id="E1" events="15" subjects_affected="12" subjects_at_risk="218"/>
                <counts group_id="E2" events="5" subjects_affected="5" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Substance Related Disorders</sub_title>
                <description>Includes substance dependence or withdrawal</description>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Sleep Disorders</sub_title>
                <description>Includes fatigue, sleepiness, somnolence and insomnia</description>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="218"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>Urinary Issues</sub_title>
                <description>Includes decreased urine output, bladder infection, hematuria, incontinence, dysuria, pelvic pain, urinary hesitance, retention, urgency or tract infection</description>
                <counts group_id="E1" events="24" subjects_affected="23" subjects_at_risk="218"/>
                <counts group_id="E2" events="8" subjects_affected="7" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Male Reproductive System Issues</sub_title>
                <description>Includes epididymitis, erectile dysfunction, inguinal or testicular pain, rectocele and retrograde ejaculation</description>
                <counts group_id="E1" events="8" subjects_affected="7" subjects_at_risk="218"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Female Reproductive System Issues</sub_title>
                <description>Includes abnormal PAP smear results, breast, ovarian or uterine cyst, mass or tumor, cystocele, menopause, vaginal or yeast infection</description>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Reproductive System Related Surgeries</sub_title>
                <description>Includes abortion, hysterectomy and lumpectomy</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="218"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Breathing Disorders</sub_title>
                <description>Includes dyspnea, sleep apnea, cough and asthma</description>
                <counts group_id="E1" events="6" subjects_affected="6" subjects_at_risk="218"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Respiratory Infections</sub_title>
                <description>Includes bronchitis, respiratory and sinus infection</description>
                <counts group_id="E1" events="10" subjects_affected="10" subjects_at_risk="218"/>
                <counts group_id="E2" events="6" subjects_affected="6" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Other Respiratory Disorders</sub_title>
                <description>Includes COPD, hemoptysis, pleuritic chest pain, reactive airway disease</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="218"/>
                <counts group_id="E2" events="4" subjects_affected="4" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Non-Lumbar Radiographic Observation</sub_title>
                <description>Includes disc bulge, protrusion and herniation</description>
                <counts group_id="E1" events="19" subjects_affected="19" subjects_at_risk="218"/>
                <counts group_id="E2" events="9" subjects_affected="9" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Index Procedure Related Wounds</sub_title>
                <description>Includes abscess, deep wound, dehiscence, dural injuries, erythema, drainage, inflammation, incisional hernia, incisional cellulitis, pain at incision site, suture reaction and wound infection</description>
                <counts group_id="E1" events="18" subjects_affected="17" subjects_at_risk="218"/>
                <counts group_id="E2" events="12" subjects_affected="12" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Vascular disorders</title>
            <event_list>
              <event>
                <sub_title>Blood Pressure</sub_title>
                <description>Includes hypertension and syncope</description>
                <counts group_id="E1" events="9" subjects_affected="9" subjects_at_risk="218"/>
                <counts group_id="E2" events="7" subjects_affected="7" subjects_at_risk="106"/>
              </event>
              <event>
                <sub_title>Vascular Issues</sub_title>
                <description>Includes aneurysm, arterial dissection, atherosclerosis and iliac vessel tear</description>
                <counts group_id="E1" events="4" subjects_affected="4" subjects_at_risk="218"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="106"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>The only disclosure restriction on the PI is that the sponsor can review results communications prior to public release and can embargo communications regarding trial results for a period that is more than 60 days but less than or equal to 180 days. The sponsor cannot require changes to the communication and cannot extend the embargo.</restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Associate Director of Medical and Scientific Affairs</name_or_title>
      <organization>Aesculap Inc.</organization>
      <phone>800-258-1946 ext 5173</phone>
      <email>mikhail.chkolnik@aesculap.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

